Innovation starts from the heart. At Edwards, we put patients first. We invest a significant proportion of our revenue towards research and development to drive and develop groundbreaking medical innovations for structural heart disease. As part
Innovation starts from the heart. At Edwards, we put patients first. We invest a significant proportion of our revenue towards research and development to drive and develop groundbreaking medical innovations for structural heart disease. As part
Innovation starts from the heart. At Edwards, we put patients first. We invest a significant proportion of our revenue towards research and development to drive and develop groundbreaking medical innovations for structural heart disease. As part
Innovation starts from the heart. At Edwards, we put patients first. We invest a significant proportion of our revenue towards research and development to drive and develop groundbreaking medical innovations for structural heart disease. As part
Many structural heart patients suffer from heart failure with limited options. Our Implantable Heart Failure Management (IHFM) businesss AI, Product and Platforms organization, is at the forefront of addressing these unmet patient needs through pioneering technology
Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a
Imagine how your ideas and expertise can change a patient’s life. Our Quality teams help shape the development of groundbreaking technologies to ensure each stage of our innovation process is held to the highest standards of
Director, Strategic Marketing TMTT Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of
Many structural heart patients suffer from heart failure with limited options. Our Implantable Heart Failure Management (IHFM) business’s AI, Product and Platforms organization is at the forefront of addressing these unmet patient needs through pioneering technology
Please note that this is an onsite role, and the successful candidate will be expected to work from our corporate Irvine, CA campus. Imagine how your ideas and expertise can change a patient’s life. Our Quality